In a victory for the fight against criminal networks distributing
counterfeit and adulterated drugs over the internet, the Financial Times
is reporting that eNom, the world's second-biggest registry, is to
begin screening customers for unapproved drug sales.
The report notes that under pressure from security professionals, ICANN and the White House, eNom "last week quietly retained LegitScript, a company that vets internet pharmaceutical concerns to make sure they are licensed to do business in the US."
To read this report in The Financial Times in full, see:
www.ft.com/cms/s/2/9d0bd394-c41c-11df-b827-00144feab49a.html